Felipe C. Geyer

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Medicine, Dermatology, Oncology +13

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

Konstantin J. Dedes, Daniel Wetterskog, Ana M. Mendes‐Pereira et al. · Science Translational Medicine · 2010 · 255 citations

Life Sciences, Molecular Biology, Oncology +15

Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager et al. · Nature Genetics · 2020 · 253 citations · Full text

Medicine, Immunology, Oncology +12

The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type

Britta Weigelt, Felipe C. Geyer, Rachael Natrajan et al. · The Journal of Pathology · 2009 · 236 citations · Full text

Medicine, Cancer Biology, Oncology +15

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts

Angelo L. Grauel, Beverly Nguyen, David A. Ruddy et al. · Nature Communications · 2020 · 203 citations · Full text

Medicine, Cancer Biology, Oncology +17